companies / heartpointglobal-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 1,800,0001.8M | ○ |
|---|---|---|
| founded | null | |
| hq | coral gables, fl, usa | |
| industry | unknown | |
| stage | null |
HeartPoint Global is developing the HPGS, a minimally invasive adjustable percutaneous device that replaces surgical pulmonary artery banding for paediatric and adult heart-failure patients. It targets congenital heart-defect and CHF cases especially in low- and middle-income markets where open surgery is harder to access. The implant allows post-procedure pressure adjustment without re-operation.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 1,800,0001.8M | null | ○ |
Cloudflare, WordPress 6.9.4, Mesmerize Companion 1.6.173, MonsterInsights 10.2.0, reCAPTCHA, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, imagesLoaded 2.10.1.5, ExtendThemes Mesmerize, DoubleClick Floodlight, Cloudflare Bot Management
| fact | status | src |
|---|---|---|
| Grant, $1.8M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |